Article: TransMolecular Receives Orphan Drug Designation for 131I-TM601 for the Treatment of Melanoma.

Article: Keryx Biopharmaceuticals Receives Orphan-Drug ...
PR Newswire;  September 16, 2009 ;     700+ words ... ... perifosine) has received Orphan-Drug designation from the U.S. Food and ... Keryx, commented, "The Orphan-Drug designation for perifosine in multiple ... perifosine program with this Orphan-Drug designation. We look forward to commencing ...

Article: U.S. FDA Grants Orphan Drug Designation to ...
Business Wire;  May 15, 2006 ;     700+ words ... ... Administration (FDA) has granted orphan drug designation to the company's lead ... therapy. "United States Orphan Drug designation for ovarian cancer is a ... occurred in patients. About Orphan Drug Designation Orphan Drug designations ...

Article: Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan ...
PR Newswire;  January 7, 2008 ;     700+ words ... ... today that it has received orphan drug designation from the U.S. Food and ... clinical trial and receipt of orphan drug designation are important milestones ... 180,000 people. About Orphan Drug Designation Orphan drug designation ...

Article: Xechem Receives Orphan Drug Designation From ...
Business Wire;  June 6, 2006 ;     700+ words ... ... today that it has received Orphan Drug designation from the U.S. Food and ... FDA's decision granting Orphan Drug Designation to 5-HMF. This puts Xechem ... coming months." About Orphan Drug Designation Orphan Drug status entitles ...

Article: Orphan Drug Designation Granted to Kosan's ...
PR Newswire;  October 26, 2004 ;     700+ words ... ... Program (CTEP). "This is the second orphan drug designation granted in the U.S. to Kosan and the ... it can occur in younger patients. About Orphan Drug Designation Orphan drug designation is granted by the U.S. Food and Drug ...

Article: Orphan Drug Designation Granted to Kosan's ...
PR Newswire;  October 20, 2004 ;     700+ words ... ... as monotherapy in this disease. "The orphan drug designation in the U.S. is an important milestone ... myeloma are diagnosed each year. About Orphan Drug Designation Orphan drug designation is granted by the U.S. Food and Drug ...

Article: Gemin X Biotechnologies Initiates Phase 1/2 Clinical Trial with ...
CCNMatthews Newswire;  January 6, 2005 ;     700+ words ... ... GX15-070 program and our attainment of orphan drug designation in CLL underscore the dedication of the ... life-threatening complications. About Orphan Drug Designation Orphan drug designation is an FDA program designed to encourage ...